Sanhe (1)

Refractory and Relapsed B Cell Acute Leukemia (1)

Suspended (1)

phase 1 (1)

Hebei Yanda Ludaopei Hospital (1)

China Immunotech (Beijing) Biotechnology Co., Ltd. (1)

cd19/cd22-dual-star-t (1)

biological (1)

Other (1)

Interventional (1)

refractory and relapsed b cell acute leukemia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Suspended

Jan 29, 2022